Management of inflammation in cardiovascular diseases

Area of Science:

• Cardiovascular Medicine
• Immunology
• Molecular Biology

Background:

• Cardiovascular disease (CVD) is a major global health burden.
• Inflammation plays a critical role in CVD progression, often exacerbated by comorbidities like diabetes and obesity.
• Immune cells and their secreted cytokines are central mediators of cardiac inflammation.

Purpose of the Study:

• To review the role of specific immune cells and cytokines in cardiac inflammation.
• To explore the balance between pro-inflammatory and anti-inflammatory cytokines in cardiovascular health.
• To highlight recent therapeutic strategies targeting cardiac inflammation.

Main Methods:

• Literature review of scientific articles and clinical trials.
• Analysis of the molecular pathways involved in cytokine-mediated cardiac inflammation.
• Synthesis of current understanding of immune cell involvement in CVD.

Main Results:

• Pro-inflammatory cytokines (IL-1β, IL-6, TNFα, IFNγ) are linked to cardiac inflammation.
• Anti-inflammatory cytokines (IL-10, TGFβ) promote inflammation resolution and cardiac repair.
• Interleukin-10 (IL-10) demonstrates protective effects via specific molecular pathways (SMAD2, p53, HuR, miR-375, miR-21).

Conclusions:

• Immune cell-derived cytokines critically regulate cardiac inflammation and CVD.
• Targeting inflammatory pathways presents a promising therapeutic avenue for cardiovascular diseases.
• Further research into anti-inflammatory strategies may alleviate cardiovascular morbidity and mortality.